Načítá se...
CON: COVID-19 will not result in increased antimicrobial resistance prevalence
Antimicrobial resistance (AMR) is affected by many factors, but too much of our focus has been on antimicrobial usage. The major factor that drives resistance rates globally is spread. The COVID-19 pandemic should lead to improved infection prevention and control practices, both in healthcare facili...
Uloženo v:
| Vydáno v: | JAC Antimicrob Resist |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7454599/ https://ncbi.nlm.nih.gov/pubmed/34192249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jacamr/dlaa051 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|